{"parse":{"title":"Antibiotic resistance in gonorrhea","pageid":35672682,"revid":814232197,"text":{"*":"<div class=\"mw-parser-output\"><div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:NeisseriaGonorrhoeae.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/56/NeisseriaGonorrhoeae.jpg/220px-NeisseriaGonorrhoeae.jpg\" width=\"220\" height=\"144\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/5/56/NeisseriaGonorrhoeae.jpg/330px-NeisseriaGonorrhoeae.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/56/NeisseriaGonorrhoeae.jpg/440px-NeisseriaGonorrhoeae.jpg 2x\" data-file-width=\"700\" data-file-height=\"458\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:NeisseriaGonorrhoeae.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Gram stain of <i>Neisseria gonorrhoeae</i> showing characteristic diplococci morphology</div></div></div>\n<p>The Gonorrhea bacterium <a href=\"/wiki/Neisseria_gonorrhoeae\" title=\"Neisseria gonorrhoeae\">Neisseria gonorrhoeae</a> has developed <a href=\"/wiki/Antimicrobial_resistance\" title=\"Antimicrobial resistance\">antibiotic resistance</a> to many antibiotics.\n</p><p>The bacteria was first identified in 1879,<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup> although some Biblical scholars believe that references to the disease can be found as early as Parshat Metzora of the <a href=\"/wiki/Old_Testament\" title=\"Old Testament\">Old Testament</a>.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>\n</p><p>In the 1940s effective treatment with <a href=\"/wiki/Penicillin\" title=\"Penicillin\">penicillin</a> became available, but by the 1970s resistant strains predominated. Resistance to penicillin has developed through two mechanisms: chromasomally mediated resistance (CMRNG) and penicillinase-mediated resistance (PPNG). CMRNG involves step wise mutation of penA, which codes for the <a href=\"/wiki/Penicillin_binding_proteins\" title=\"Penicillin binding proteins\">penicillin-binding protein</a> (PBP-2); mtr, which encodes an <a href=\"/wiki/Efflux_(microbiology)\" title=\"Efflux (microbiology)\">efflux pump</a> that removes penicillin from the cell; and penB, which encodes the bacterial cell wall <a href=\"/wiki/Porin_(protein)\" title=\"Porin (protein)\">porins</a>. PPNG involves the acquisition of a <a href=\"/wiki/Plasmid-mediated_resistance\" title=\"Plasmid-mediated resistance\">plasmid-borne</a> <a href=\"/wiki/Beta-lactamase\" title=\"Beta-lactamase\">beta-lactamase</a>.<sup id=\"cite_ref-Tapsall_2001_3-0\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup> <i>N. gonorrheoea</i> has a high affinity for <a href=\"/wiki/Horizontal_gene_transfer\" title=\"Horizontal gene transfer\">horizontal gene transfer</a>, and as a result, the existence of any strain resistant to a given drug could spread easily across strains.\n</p><p><a href=\"/wiki/Quinolone_antibiotic\" title=\"Quinolone antibiotic\">Fluoroquinolones</a> were a useful next-line treatment until resistance was achieved through efflux pumps and mutations to the gyrA gene, which encodes <a href=\"/wiki/DNA_gyrase\" title=\"DNA gyrase\">DNA gyrase</a>.<sup id=\"cite_ref-Tapsall_2001_3-1\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup> Third-generation <a href=\"/wiki/Cephalosporins\" class=\"mw-redirect\" title=\"Cephalosporins\">cephalosporins</a> have been used to treat gonorrhoea since 2007, but resistant strains have emerged. As of 2010, the recommended treatment is a single 250&#160;mg intramuscular injection of <a href=\"/wiki/Ceftriaxone\" title=\"Ceftriaxone\">ceftriaxone</a>, sometimes in combination with <a href=\"/wiki/Azithromycin\" title=\"Azithromycin\">azithromycin</a> or <a href=\"/wiki/Doxycycline\" title=\"Doxycycline\">doxycycline</a>.<sup id=\"cite_ref-Japan10_4-0\" class=\"reference\"><a href=\"#cite_note-Japan10-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-MMWR2012_5-0\" class=\"reference\"><a href=\"#cite_note-MMWR2012-5\">&#91;5&#93;</a></sup> However, certain strains of <i>N. gonorrhoeae</i> can be resistant to antibiotics usually that are normally used to treat it. These include: <a href=\"/wiki/Cefixime\" title=\"Cefixime\">cefixime</a> (an oral <a href=\"/wiki/Cephalosporin\" title=\"Cephalosporin\">cephalosporin</a>), <a href=\"/wiki/Ceftriaxone\" title=\"Ceftriaxone\">ceftriaxone</a> (an injectable cephalosporin), <a href=\"/wiki/Azithromycin\" title=\"Azithromycin\">azithromycin</a>, <a href=\"/wiki/Aminoglycosides\" class=\"mw-redirect\" title=\"Aminoglycosides\">aminoglycosides</a>, and <a href=\"/wiki/Tetracycline\" title=\"Tetracycline\">tetracycline</a>.<sup id=\"cite_ref-CDC2013_6-0\" class=\"reference\"><a href=\"#cite_note-CDC2013-6\">&#91;6&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Penicillins\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Penicillins</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Quinolones\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Quinolones</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Cephalosporins\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Cephalosporins</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Tetracyclines\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Tetracyclines</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Aminoglycosides\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Aminoglycosides</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#See_also\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#References\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Penicillins\">Penicillins</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antibiotic_resistance_in_gonorrhea&amp;action=edit&amp;section=1\" title=\"Edit section: Penicillins\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Penicillin_cures_gonorrhea.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/cb/Penicillin_cures_gonorrhea.jpg/220px-Penicillin_cures_gonorrhea.jpg\" width=\"220\" height=\"178\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/cb/Penicillin_cures_gonorrhea.jpg/330px-Penicillin_cures_gonorrhea.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/c/cb/Penicillin_cures_gonorrhea.jpg 2x\" data-file-width=\"422\" data-file-height=\"342\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Penicillin_cures_gonorrhea.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Old advertisement for penicillin treatment</div></div></div>\n<p>Beta-lactams like penicillin were widely used to treat gonorrhea in the 1940s.  There are three general mechanisms that may allow bacteria to become resistant to beta-lactam antibiotics:\n</p>\n<ol><li>inability to access/target penicillin-binding protein (PBP) enzyme</li>\n<li>inhibition of binding to PBP via modification of the enzyme</li>\n<li>hydrolysis/inactivation of the antibiotic by beta-lactamases.<sup id=\"cite_ref-Murray_7-0\" class=\"reference\"><a href=\"#cite_note-Murray-7\">&#91;7&#93;</a></sup></li></ol>\n<p>Overuse of penicillin contributed to <i>Neisseria gonorrhoeae</i> developing high resistance to penicillin through two main mechanisms: chromosomally mediated resistance (CMRNG) and penicillinase-mediated resistance (PPNG).<sup id=\"cite_ref-Tapsall_2001_3-2\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>\n</p><p>Chromosomally mediated resistance occurred through step-wise changes over many years.  Chromosomal mutations in the <i>penA</i>, <i>mtr</i>, and <i>penB</i> genes are the major mechanisms for CMRNG.  The <i>penA</i> gene encodes an alternative penicillin-binding protein, PBP-2.<sup id=\"cite_ref-Tapsall_2001_3-3\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>  This mechanism falls under the second general mechanism for beta-lactam resistance.  PBPs, also known as transpeptidases, are targets for beta-lactams.  These enzymes (PBPs) are involved in peptidoglycan synthesis which is a major component of the bacterial cell wall.  PBPs cross-link the amino acid strands of peptidoglycan during synthesis.  Normally, beta-lactams bind the PBPs and thereby inhibit the cross-linking of peptidoglycan.  When this occurs, the cell wall of the bacterium is compromised and often results in cell death.<sup id=\"cite_ref-Murray_7-1\" class=\"reference\"><a href=\"#cite_note-Murray-7\">&#91;7&#93;</a></sup>  When <i>N. gonorrhoeae</i> encodes <i>penA</i>, the new PBP-2 that is synthesized is no longer recognized by the beta-lactams rendering the bacterium resistant.\n</p><p>The <i>mtr</i> (multiple transferable resistance) gene encodes for an efflux pump.<sup id=\"cite_ref-Rouquette-Loughlin_8-0\" class=\"reference\"><a href=\"#cite_note-Rouquette-Loughlin-8\">&#91;8&#93;</a></sup>  Efflux pumps mediate resistance to a variety of compounds including antibiotics, detergents, and dyes.<sup id=\"cite_ref-Tapsall_2001_3-4\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>  This mechanism falls under the first general resistance mechanism to beta-lactams.  <i>mtr</i> encodes for the protein MtrD which is the efflux pump for <i>N. gonorrhoeae</i>.<sup id=\"cite_ref-Tapsall_2001_3-5\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>  MtrD is among the Resistance Nodulation Division (RND) efflux pump superfamily.  These pumps are proton antiporters where the antibiotic is pumped out of the cell while a proton is pumped into the cell.<sup id=\"cite_ref-Van_Bambeke_9-0\" class=\"reference\"><a href=\"#cite_note-Van_Bambeke-9\">&#91;9&#93;</a></sup>\n</p><p>The cell wall of <i>N. gonorrhoeae</i> contains porins which are holes within the cell wall in which some molecules are able to diffuse into or out of the cell membrane.  This mechanism falls under the first general mechanism for beta-lactam resistance.  The <i>penB</i> gene encodes the porins for <i>N. gonorrhoeae</i> and when this gene undergoes mutations, there is a decrease in permeability of the cell wall to hydrophilic antibiotics like penicillin.<sup id=\"cite_ref-Tapsall_2001_3-6\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>\n</p><p>Penicillinase-mediated resistance in <i>N. gonorrhoeae</i> is mediated by the plasmid borne TEM-1 type beta-lactamase which falls under the third general mechanism for beta-lactam resistance.<sup id=\"cite_ref-Tapsall_2001_3-7\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>  There have been over 200 beta-lactamases described and some of them are antibiotic specific.<sup id=\"cite_ref-Murray_7-2\" class=\"reference\"><a href=\"#cite_note-Murray-7\">&#91;7&#93;</a></sup>  TEM-1 is a penicillinase specific for penicillins.  This enzyme will bind to the beta-lactam ring which is a structural characteristic for beta-lactams and hydrolyze the ring.  This renders the antibiotic inactive.  The spread of the penicillinase resistance was much faster compared to the chromosomal-mediated resistance mechanisms.  The plasmids containing TEM-1 could be passed from bacterium to bacterium via conjugation <sup id=\"cite_ref-Tapsall_2001_3-8\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Quinolones\">Quinolones</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antibiotic_resistance_in_gonorrhea&amp;action=edit&amp;section=2\" title=\"Edit section: Quinolones\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Quinolones are a class of synthetic antibiotics that inhibit DNA replication, recombination, and repair by interacting with the bacterial DNA gyrase and/or topoisomerase IV.<sup id=\"cite_ref-Murray_7-3\" class=\"reference\"><a href=\"#cite_note-Murray-7\">&#91;7&#93;</a></sup>  Second generation quinolones like ciprofloxacin and ofloxacin have been widely used to treat <i>N. gonorrhoeae</i> infections.  Resistance to these antibiotics has developed over the years with chromosomal resistance being the primary mechanism.<sup id=\"cite_ref-Tapsall_2001_3-9\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>\n</p><p>Low-level quinolone resistance has been linked to changes in cell permeability and efflux pumps.  The NorM efflux pump is encoded by the <i>norM</i> gene and provides resistance to fluoroquinolones.<sup id=\"cite_ref-Rouquette-Loughlin_8-1\" class=\"reference\"><a href=\"#cite_note-Rouquette-Loughlin-8\">&#91;8&#93;</a></sup>  The NorM efflux pump is a member of the MATE (multidrug and toxic compound extrusion) family and functions by a Na+ antiporter.  It is also known that a point mutation upstream of the <i>norM</i> gene will causes overexpression of NorM, and mediate elevated resistance.<sup id=\"cite_ref-Rouquette-Loughlin_8-2\" class=\"reference\"><a href=\"#cite_note-Rouquette-Loughlin-8\">&#91;8&#93;</a></sup>\n</p><p>High-level resistance to quinolones has been seen through target modification acting on the DNA gyrase and topoisomerase IV.  Multiple amino acid substation mutations in the <i>gyrA</i> gene, which encodes for the DNA gyrase, have been seen extensively.  DNA gyrase is an enzyme that binds to DNA and introduces negative supercoiling.<sup id=\"cite_ref-Drlica_10-0\" class=\"reference\"><a href=\"#cite_note-Drlica-10\">&#91;10&#93;</a></sup>  This helps unwind the DNA for replication.  If there is a mutation in the DNA gyrase, then the quinolone will not be able to bind to it resulting in the activity of DNA gyrase not being inhibited.  Multiple mutations have also been noted in the <i>parC</i> gene which encodes for the topoisomerase IV.  Topoisomerase IV acts similarly to DNA gyrase and is involved in unwinding DNA for replication.<sup id=\"cite_ref-Drlica_10-1\" class=\"reference\"><a href=\"#cite_note-Drlica-10\">&#91;10&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Cephalosporins\">Cephalosporins</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antibiotic_resistance_in_gonorrhea&amp;action=edit&amp;section=3\" title=\"Edit section: Cephalosporins\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Beta-lactam_antibiotics_example_1.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/Beta-lactam_antibiotics_example_1.svg/220px-Beta-lactam_antibiotics_example_1.svg.png\" width=\"220\" height=\"332\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/Beta-lactam_antibiotics_example_1.svg/330px-Beta-lactam_antibiotics_example_1.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d8/Beta-lactam_antibiotics_example_1.svg/440px-Beta-lactam_antibiotics_example_1.svg.png 2x\" data-file-width=\"510\" data-file-height=\"770\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Beta-lactam_antibiotics_example_1.svg\" class=\"internal\" title=\"Enlarge\"></a></div>Basic structures of penicillins(1) and cephalosporins(2) with beta-lactam ring highlighted in red</div></div></div>\n<p><a href=\"/wiki/Ceftriaxone\" title=\"Ceftriaxone\">Ceftriaxone</a> and <a href=\"/wiki/Cefixime\" title=\"Cefixime\">cefixime</a> are third generation cephalosporins and are often used as treatments for <i>N. gonorrhoeae infections</i>.<sup id=\"cite_ref-Tapsall_2001_3-10\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>  The cephalosporins are part of a larger beta-lactam family of antibiotics.<sup id=\"cite_ref-Wilson_11-0\" class=\"reference\"><a href=\"#cite_note-Wilson-11\">&#91;11&#93;</a></sup>  The newly discovered H041 strain of <i>N. gonorrhoeae</i>, originally isolated from a commercial sex worker in Japan, was shown to be resistant to this antibiotic.<sup id=\"cite_ref-Golparian_12-0\" class=\"reference\"><a href=\"#cite_note-Golparian-12\">&#91;12&#93;</a></sup>\n</p><p>The possible mechanisms of resistance to this antibiotic are as follows:\n</p>\n<ol><li>an alteration of more than four amino acids in the C-terminal end of the PBP-2,<sup id=\"cite_ref-Unemo_13-0\" class=\"reference\"><a href=\"#cite_note-Unemo-13\">&#91;13&#93;</a></sup> which would result in the antibiotic being unable to bind to its target</li>\n<li>mutations in the promoter regions of <i>mtr</i>, resulting in the overexpression of genes that code for efflux pumps</li>\n<li>mutations in the <i>penB</i> gene that encodes for the bacterial porin.  This form of resistance has only been observed with ceftriaxone which is administered through an intramuscular injection.<sup id=\"cite_ref-Tapsall_2001_3-11\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup></li></ol>\n<h2><span class=\"mw-headline\" id=\"Tetracyclines\">Tetracyclines</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antibiotic_resistance_in_gonorrhea&amp;action=edit&amp;section=4\" title=\"Edit section: Tetracyclines\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Tetracyclines are a class of antibiotics that inhibit protein synthesis by binding to the 30s ribosomal subunit of bacterial cells, keeping transcription of the bacterial genome from occurring.<sup id=\"cite_ref-Wilson_11-1\" class=\"reference\"><a href=\"#cite_note-Wilson-11\">&#91;11&#93;</a></sup>  Tetracyclines are bacteriostatic, which means that the growth of the bacterium will be slowed.<sup id=\"cite_ref-Murray_7-4\" class=\"reference\"><a href=\"#cite_note-Murray-7\">&#91;7&#93;</a></sup>  Tetracyclines are not often recommended for the treatment of <i>N. gonorrhoeae</i> because the treatment regimen requires many doses, which may affect compliance and contribute to resistance.<sup id=\"cite_ref-Tapsall_2001_3-12\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>  Tetracycline is still used as treatment for this infection in developing countries because the cost for the drug is low <sup id=\"cite_ref-Tapsall_2001_3-13\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>\n</p><p>As with the penicillin resistance, the <i>penB</i> (porin formation) and <i>mtr</i> (efflux pump formation) mutations mediate chromosomal resistance.  These adaptations will also affect the ability of the antibiotic to get into, or stay in the bacterial cell.  High level resistance of <i>N. gonorrhoeae</i> to tetracyclines was first reported in 1986 with the discovering of the <i>tetM</i> determinant.<sup id=\"cite_ref-Tapsall_2001_3-14\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>  The mechanism of resistance is still unknown.\n</p>\n<h2><span class=\"mw-headline\" id=\"Aminoglycosides\">Aminoglycosides</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antibiotic_resistance_in_gonorrhea&amp;action=edit&amp;section=5\" title=\"Edit section: Aminoglycosides\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><i>N. gonorrhoeae</i> has also shown resistance to the aminoglycoside class of antibiotics. These antibiotics bind to the 16s rRNA of the 30S subunit of the bacterial ribosome,<sup id=\"cite_ref-Wilson_11-2\" class=\"reference\"><a href=\"#cite_note-Wilson-11\">&#91;11&#93;</a></sup> thereby stopping transcription of the bacterial genome.  Resistance appears to be acquired through porin-related mechanisms, much like the cephalosporin resistance mechanism.  This mechanism would result in the access of the antibiotic to the bacterial cell being inhibited.  There is a possibility of future enzymes (made by the bacterium) that will be able to denature and inactivate the aminoglycosides.<sup id=\"cite_ref-Tapsall_2001_3-15\" class=\"reference\"><a href=\"#cite_note-Tapsall_2001-3\">&#91;3&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antibiotic_resistance_in_gonorrhea&amp;action=edit&amp;section=6\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><i><a href=\"/wiki/Neisseria_gonorrhoeae\" title=\"Neisseria gonorrhoeae\">Neisseria gonorrhoeae</a></i></li>\n<li><i><a href=\"/wiki/Antibiotic_resistance\" class=\"mw-redirect\" title=\"Antibiotic resistance\">Antibiotic resistance</a></i></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antibiotic_resistance_in_gonorrhea&amp;action=edit&amp;section=7\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ligon BL (2005). <a rel=\"nofollow\" class=\"external text\" href=\"https://linkinghub.elsevier.com/retrieve/pii/S1045-1870(05)00076-2\">\"Albert Ludwig Sigesmund Neisser: discoverer of the cause of gonorrhea\"</a>. <i>Semin Pediatr Infect Dis</i>. <b>16</b> (4): 336\u201341. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1053/j.spid.2005.07.001\">10.1053/j.spid.2005.07.001</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16210113\">16210113</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Semin+Pediatr+Infect+Dis&amp;rft.atitle=Albert+Ludwig+Sigesmund+Neisser%3A+discoverer+of+the+cause+of+gonorrhea&amp;rft.volume=16&amp;rft.issue=4&amp;rft.pages=336-41&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1053%2Fj.spid.2005.07.001&amp;rft_id=info%3Apmid%2F16210113&amp;rft.aulast=Ligon&amp;rft.aufirst=BL&amp;rft_id=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1045-1870%2805%2900076-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntibiotic+resistance+in+gonorrhea\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Rosner, Fred (1995). <i>Medicine in the Bible and the Talmud&#160;: selections from classical Jewish sources</i> (Augm. ed.). Hoboken, NJ: KTAV Pub. House. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-88125-506-8\" title=\"Special:BookSources/0-88125-506-8\">0-88125-506-8</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Medicine+in+the+Bible+and+the+Talmud+%3A+selections+from+classical+Jewish+sources&amp;rft.place=Hoboken%2C+NJ&amp;rft.edition=Augm.&amp;rft.pub=KTAV+Pub.+House&amp;rft.date=1995&amp;rft.isbn=0-88125-506-8&amp;rft.aulast=Rosner&amp;rft.aufirst=Fred&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntibiotic+resistance+in+gonorrhea\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Tapsall_2001-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Tapsall_2001_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-Tapsall_2001_3-15\"><sup><i><b>p</b></i></sup></a></span> <span class=\"reference-text\">Tapsall (2001) Antimicrobial resistance in <i>Niesseria gonorrhoeae</i>. World Health Organization.</span>\n</li>\n<li id=\"cite_note-Japan10-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Japan10_4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Deguchi T, Nakane K, Yasuda M, Maeda S (September 2010). \"Emergence and spread of drug resistant Neisseria gonorrhoeae\". <i>J. Urol</i>. <b>184</b> (3): 851\u20138; quiz 1235. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.juro.2010.04.078\">10.1016/j.juro.2010.04.078</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20643433\">20643433</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Urol.&amp;rft.atitle=Emergence+and+spread+of+drug+resistant+Neisseria+gonorrhoeae&amp;rft.volume=184&amp;rft.issue=3&amp;rft.pages=851-8%3B+quiz+1235&amp;rft.date=2010-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.juro.2010.04.078&amp;rft_id=info%3Apmid%2F20643433&amp;rft.aulast=Deguchi&amp;rft.aufirst=T&amp;rft.au=Nakane%2C+K&amp;rft.au=Yasuda%2C+M&amp;rft.au=Maeda%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntibiotic+resistance+in+gonorrhea\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-MMWR2012-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-MMWR2012_5-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Centers for Disease Control Prevention (CDC). (Aug 10, 2012). \"Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections\". <i>MMWR. Morbidity and Mortality Weekly Report</i>. <b>61</b> (31): 590\u20134. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22874837\">22874837</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MMWR.+Morbidity+and+Mortality+Weekly+Report&amp;rft.atitle=Update+to+CDC%27s+Sexually+Transmitted+Diseases+Treatment+Guidelines%2C+2010%3A+Oral+Cephalosporins+No+Longer+a+Recommended+Treatment+for+Gonococcal+Infections&amp;rft.volume=61&amp;rft.issue=31&amp;rft.pages=590-4&amp;rft.date=2012-08-10&amp;rft_id=info%3Apmid%2F22874837&amp;rft.au=Centers+for+Disease+Control+Prevention+%28CDC%29.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntibiotic+resistance+in+gonorrhea\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-CDC2013-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-CDC2013_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cdc.gov/drugresistance/biggest_threats.html\">\"Biggest Threats - Antibiotic/Antimicrobial Resistance - CDC\"</a>. <i>www.cdc.gov</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2016-05-05</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.cdc.gov&amp;rft.atitle=Biggest+Threats+-+Antibiotic%2FAntimicrobial+Resistance+-+CDC&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fdrugresistance%2Fbiggest_threats.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntibiotic+resistance+in+gonorrhea\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Murray-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Murray_7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Murray_7-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Murray_7-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Murray_7-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Murray_7-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\">Murray, Patrick R., Ken S. Rosenthal, and Michael A. Pfaller. Medical Microbiology. 6th ed. Philadelphia: Mosby/Elsevier, 2009. Print</span>\n</li>\n<li id=\"cite_note-Rouquette-Loughlin-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Rouquette-Loughlin_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Rouquette-Loughlin_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Rouquette-Loughlin_8-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\">Rouquette-Loughlin, Dunham, Kuhn, Balthazar, Shafer (2003) The NorM Efflux Pump of <i>Neisseria gonorrhoeae</i> and <i>Neissera meningitidis</i> Recognizes Antimicrobial Cationic Compounds. Journal of Bacteriology 185:1101\u20131106</span>\n</li>\n<li id=\"cite_note-Van_Bambeke-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Van_Bambeke_9-0\">^</a></b></span> <span class=\"reference-text\">Van Bambeke, Balzi, Tulkens (2000) Antibiotic Efflux Pumps. Biochemical Pharmacology 60:457\u2013470</span>\n</li>\n<li id=\"cite_note-Drlica-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Drlica_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Drlica_10-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Drlica, Zhao (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiology and Molecular Biology Reviews 61:377\u2013392</span>\n</li>\n<li id=\"cite_note-Wilson-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Wilson_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Wilson_11-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Wilson_11-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\">Wilson, Brenda A., Abigail A. Salyers, Dixie D. Whitt, and Malcolm A. Winkler. Bacterial Pathogenesis: A Molecular Approach. 3rd ed. Washington DC: ASM Press, 2011. Print.</span>\n</li>\n<li id=\"cite_note-Golparian-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Golparian_12-0\">^</a></b></span> <span class=\"reference-text\">Unemo, Golparian, Nicholas, Ohnishi, Gallay, Sednaoui (2011) High-Level Cefixime- and Ceftriaxone-Resistant <i>Neisseria gonorrhoeae</i> in France: Novel <i>penA</i> Mosaic Allele in a Successful International Clone Causes Treatment Failure. Antimicrobial Agents and Chemotherapy 1273\u20131280</span>\n</li>\n<li id=\"cite_note-Unemo-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Unemo_13-0\">^</a></b></span> <span class=\"reference-text\">Unemo (2008) Real-time PCR and subsequent pyrosequencing for screeing of <i>penA</i> mosaic alleles and prediction of reduced susceptibility to expanded-spectrum cephalosorins in <i>Neisseria gonorrhoeae</i>. Acta Pathologica, Microbiologica et Immunologica Scandinavica 116:1001\u20131008</span>\n</li>\n</ol></div>\n\n<!-- \nNewPP limit report\nParsed by mw1247\nCached time: 20180908210202\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.152 seconds\nReal time usage: 0.191 seconds\nPreprocessor visited node count: 529/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 9730/2097152 bytes\nTemplate argument size: 115/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 14164/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.044/10.000 seconds\nLua memory usage: 2.35 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  104.351      1 Template:Reflist\n100.00%  104.351      1 -total\n 61.89%   64.584      3 Template:Cite_journal\n  6.11%    6.371      1 Template:Cite_web\n  5.79%    6.046      1 Template:Cite_book\n  2.39%    2.499      1 Template:Main_other\n  2.03%    2.114      1 Template:Column-width\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:35672682-0!canonical and timestamp 20180908210202 and revision id 814232197\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","*":"Sexually_transmitted_diseases_and_infections"},{"sortkey":"","*":"Antibiotic-resistant_bacteria"}],"links":[{"ns":0,"exists":"","*":"Aminoglycosides"},{"ns":0,"exists":"","*":"Antibiotic resistance"},{"ns":0,"exists":"","*":"Antimicrobial resistance"},{"ns":0,"exists":"","*":"Azithromycin"},{"ns":0,"exists":"","*":"Beta-lactamase"},{"ns":0,"exists":"","*":"Cefixime"},{"ns":0,"exists":"","*":"Ceftriaxone"},{"ns":0,"exists":"","*":"Cephalosporin"},{"ns":0,"exists":"","*":"Cephalosporins"},{"ns":0,"exists":"","*":"DNA gyrase"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Doxycycline"},{"ns":0,"exists":"","*":"Efflux (microbiology)"},{"ns":0,"exists":"","*":"Horizontal gene transfer"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Neisseria gonorrhoeae"},{"ns":0,"exists":"","*":"Old Testament"},{"ns":0,"exists":"","*":"Penicillin"},{"ns":0,"exists":"","*":"Penicillin binding proteins"},{"ns":0,"exists":"","*":"Plasmid-mediated resistance"},{"ns":0,"exists":"","*":"Porin (protein)"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Quinolone antibiotic"},{"ns":0,"exists":"","*":"Tetracycline"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["NeisseriaGonorrhoeae.jpg","Penicillin_cures_gonorrhea.jpg","Beta-lactam_antibiotics_example_1.svg"],"externallinks":["https://linkinghub.elsevier.com/retrieve/pii/S1045-1870(05)00076-2","//doi.org/10.1053/j.spid.2005.07.001","//www.ncbi.nlm.nih.gov/pubmed/16210113","//doi.org/10.1016/j.juro.2010.04.078","//www.ncbi.nlm.nih.gov/pubmed/20643433","//www.ncbi.nlm.nih.gov/pubmed/22874837","https://www.cdc.gov/drugresistance/biggest_threats.html"],"sections":[{"toclevel":1,"level":"2","line":"Penicillins","number":"1","index":"1","fromtitle":"Antibiotic_resistance_in_gonorrhea","byteoffset":3707,"anchor":"Penicillins"},{"toclevel":1,"level":"2","line":"Quinolones","number":"2","index":"2","fromtitle":"Antibiotic_resistance_in_gonorrhea","byteoffset":7869,"anchor":"Quinolones"},{"toclevel":1,"level":"2","line":"Cephalosporins","number":"3","index":"3","fromtitle":"Antibiotic_resistance_in_gonorrhea","byteoffset":9786,"anchor":"Cephalosporins"},{"toclevel":1,"level":"2","line":"Tetracyclines","number":"4","index":"4","fromtitle":"Antibiotic_resistance_in_gonorrhea","byteoffset":11737,"anchor":"Tetracyclines"},{"toclevel":1,"level":"2","line":"Aminoglycosides","number":"5","index":"5","fromtitle":"Antibiotic_resistance_in_gonorrhea","byteoffset":12922,"anchor":"Aminoglycosides"},{"toclevel":1,"level":"2","line":"See also","number":"6","index":"6","fromtitle":"Antibiotic_resistance_in_gonorrhea","byteoffset":13574,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"7","index":"7","fromtitle":"Antibiotic_resistance_in_gonorrhea","byteoffset":13655,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Antibiotic resistance in gonorrhea","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q16154222"}]}}